InsiderSignal.AI

InsiderSignal.ai

CNC - Centene Corp

Insider Purchase by Samuels Theodore R. II (Dir)

1 Year
After Trade
Before Trade

Loading data...

Trade Summary

6 months ago, Samuels Theodore R. II, serving as Dir at Centene Corp (CNC), purchased 9,000 shares at $27.62 per share, for a total transaction value of $248,580.00. Following this transaction, Samuels Theodore R. II now holds 50,495 shares of CNC.

This purchase represents a 22.00% increase in Samuels Theodore R. II's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, July 28, 2025 and publicly disclosed via SEC Form 4 filing on Tuesday, July 29, 2025, 1 day after the trade was made.

Centene Corp operates in the HEALTHCARE sector, specifically within the HEALTHCARE PLANS industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.

Samuels Theodore R. II

Dir

Theodore R. Samuels II is a retired financial executive serving as an independent director on the board of Centene Corporation since 2022, where he is a member of the Compensation and Talent Committee and Governance Committee.[[5]](https://www.marketscreener.com/insider/THEODORE-SAMUELS-A037B6/)[[7]](https://www.centene.com/who-we-are/board-of-directors.html)[[9]](https://investors.centene.com/Theodore-R-Samuels) He recently demonstrated confidence in the company by purchasing 9,000 shares of Centene (NYSE: CNC) common stock on July 28, 2025, at $27.62 per share for $248,580, bringing his direct ownership to 18,494.979 shares (including restricted stock units), plus 32,000 shares indirectly through a family trust where he is co-trustee, and options for 10,000 shares.[[1]](https://www.investing.com/news/insider-trading-news/centene-director-samuels-buys-248k-in-company-stock-93CH-4158713)[[3]](https://www.ainvest.com/news/centene-director-large-stock-purchase-boosting-investor-confidence-2507/)[[6]](https://www.stocktitan.net/sec-filings/CNC/form-4-centene-corp-insider-trading-activity-ae0e7ab5923b.html) Samuels has a distinguished career in investment management, having served as President of Capital Guardian Trust Company from 2010 to 2017 and as a global equity portfolio manager at Capital International, Inc. from 1981 to 2012.[[2]](https://www.bms.com/about-us/leadership/board-of-directors/theodore-r-samuels.html)[[5]](https://www.marketscreener.com/insider/THEODORE-SAMUELS-A037B6/)[[8]](https://www.directorsandboards.com/roster_individual/theodore-r-samuels/) He currently holds lead independent director positions at Bristol Myers Squibb (since 2017) and Iron Mountain Inc. (since 2023), with prior board roles at Perrigo Company (2017-2023), Auctane, Inc. (2017-2021), and others including Children's Hospital Los Angeles and Research Corporation Technologies.[[2]](https://www.bms.com/about-us/leadership/board-of-directors/theodore-r-samuels.html)[[5]](https://www.marketscreener.com/insider/THEODORE-SAMUELS-A037B6/)[[8]](https://www.directorsandboards.com/roster_individual/theodore-r-samuels/)

View full insider profile →

Trade Price

$27.62

Quantity

9,000

Total Value

$248,580.00

Shares Owned

50,495

Trade Date

Monday, July 28, 2025

209 days ago

SEC Filing Date

Tuesday, July 29, 2025

Filed 1 day after trade

HEALTHCAREHEALTHCARE PLANS

About Centene Corp

Company Overview

No company information available
View news mentioning CNC

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/89826

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

Create Free AccountLearn More

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime